DUBLIN, September 15, 2017 /PRNewswire/ --
The "Global Orthopedic Soft Tissue Repair Devices Market 2017-2021" report has been added to Research and Markets' offering.
The global orthopedic soft tissue repair devices market to grow at a CAGR of 10.32% during the period 2017-2021.
Global Orthopedic Soft Tissue Repair Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the sales, value, retrofit, and replacement of the global orthopedic soft tissue repair devices market.
According to the report, one of the major drivers for this market is Increasing incidence of road and sports injuries. Globally, road injuries are increasing. Such injuries can damage soft tissues. According to the CDC in 2016, each year, an average of 20-30 million people is injured and disabled by road accidents. The cost of road injuries was estimated to be $518 billion per year. It also stated that the US, New Zealand, Canada, France, Japan, and Germany have seen a large number injuries and deaths due to road injuries.
The latest trend gaining momentum in the market is Strategic partnerships and collaboration activities. The orthopedic soft tissue repair devices market is characterized by the presence of many vendors, leading to intense competition. Hence, it becomes necessary for vendors to make strategic partnerships with medical universities and other manufacturing companies for product development and thereby, maintain their market shares.
Further, the report states that one of the major factors hindering the growth of this market is High cost of and failure rate in clinical trials. Most vendors conduct clinical trials in developed countries such as the US, the UK, Germany, France, Japan, Singapore, and South Korea. The cost of clinical trials and product launches can be very expensive in these regions. Most of the small vendors or start-up biotech companies seek government or private funding, which may be limited. The estimated cost of orthopedic soft tissue repair products such as cell therapy-based products from clinical development stage to commercialization can cost up to $1.5 billion to the company.
Key vendors
- Arthrex
- Stryker
- Zimmer Biomet
Other prominent vendors
- AlloSource
- RepliCel
- Orteq
- CellGenix
- Collagen Solutions
- Vericel Corporation
- BioTissue
- Geistlich
- Tornier
- XTANT MEDICAL
- TEIJIN
- Parcus Medical
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market Landscape
Part 06: Market Segmentation By Product
Part 07: Market Segmentation By Application
Part 08: Market Segmentation By End-User
Part 09: Geographical Segmentation
Part 10: Decision Framework
Part 11: Drivers And Challenges
Part 12: Market Trends
Part 13: Vendor Landscape
Part 14: Key Vendor Analysis
Part 15: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/qswhl6/global_orthopedic
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716